AMARIN CORP PLC\UK Restructuring Reserve, Translation and Other Adjustment
AMARIN CORP PLC\UK (AMRN) reported Restructuring Reserve, Translation and Other Adjustment of $454.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-03.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveTranslationAndOtherAdjustment · last filed 2022-08-03
- AMARIN CORP PLC\UK restructuring reserve, translation and other adjustment for the quarter ending 2021-12-31 was $0.00.
- AMARIN CORP PLC\UK restructuring reserve, translation and other adjustment for fiscal 2021 was -$306.00K.
| Period end | Restructuring Reserve, Translation and Other Adjustment 3 month | Restructuring Reserve, Translation and Other Adjustment 6 month | Restructuring Reserve, Translation and Other Adjustment 9 month | Restructuring Reserve, Translation and Other Adjustment 12 month |
|---|---|---|---|---|
| 2022-06-30 | $454.00K 10-Q · filed 2022-08-03 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$306.00K 10-K · filed 2022-03-01 | ||
| 2021-09-30 | -$306.00K 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |